Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1β and tumour necrosis factor α (original) (raw)
Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1β and tumour necrosis factor α
- S-M Dai1,2,
- K Nishioka1,
- K Yudoh1
- 1Department of Bioregulation, Institute of Medical Science, St Marianna University School of Medicine, Kawasaki, Japan
- 2Department of Rheumatology and Immunology, Changhai Hospital, Second Military Medical University, Shanghai, China
- Correspondence to:
Dr K Yudoh
Department of Bioregulation, Institute of Medical Science, St Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa 216-8512, Japan; yudomarianna-u.ac.jp
Abstract
Objective: To determine whether IL18 has any indirect effects on osteoclastogenesis mediated by T cells in RA synovium, and compare its effects with those of IL1β and TNFα.
Methods: Resting T cells were isolated from peripheral blood of healthy donors, and stimulated with 2 μg/ml phytohaemagglutinin (PHA) and 0.5 ng/ml IL2 for 24 hours. Synovial T cells were isolated from RA synovial tissue. The levels of soluble receptor activator of the NF-κB ligand (RANKL), osteoprotegerin (OPG), IFNγ, M-CSF, and GM-CSF were determined by ELISA. Membrane bound RANKL expression was analysed by flow cytometry. Commercially available human osteoclast precursors were cocultured with T cells to induce osteoclast formation, which was determined with tartrate resistant acid phosphatase staining and pit formation assay.
Results: In PHA prestimulated T cells or RA synovial T cells, IL18, IL1β, or TNFα increased soluble RANKL production and membrane bound RANKL expression in a dose dependent manner. IL18, IL1β, and TNFα did not induce M-CSF, GM-CSF, IFNγ, or OPG production in PHA prestimulated T cells or RA synovial T cells. IL18 increased the number of osteoclasts and bone resorption area on dentine slices in the coculture of human osteoclast precursors with PHA prestimulated T cells or RA synovial T cells; its ability was equivalent to that of IL1β, but less potent than that of TNFα. In the coculture system, OPG completely blocked osteoclast induction by IL18 or IL1β, and greatly inhibited induction by TNFα.
Conclusion: IL18, IL1β, or TNFα can indirectly stimulate osteoclast formation through up regulation of RANKL production from T cells in RA synovitis; IL18 is as effective as IL1β, but less potent than TNFα.
- ELISA, enzyme linked immunosorbent assay
- FCS, fetal calf serum
- GM-CSF, granulocyte monocyte-colony stimulating factor
- IFNγ, interferon γ
- IL, interleukin
- M-CSF, monocyte/macrophage-colony stimulating factor
- α-MEM, α-minimal essential medium
- MFI, mean fluorescence intensity
- OPG, osteoprotegerin
- PBS, phosphate buffered saline
- PHA, phytohaemagglutinin
- RA, rheumatoid arthritis
- RANK, receptor activator of NF-κB
- RANKL, receptor activator of NF-κB ligand
- TNFα, tumour necrosis factor α
- TRAP, tartrate resistant acid phosphatase
- interleukin 18
- interleukin 1β
- tumour necrosis factor α
- osteoclasts
- rheumatoid arthritis
Statistics from Altmetric.com
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
- ELISA, enzyme linked immunosorbent assay
- FCS, fetal calf serum
- GM-CSF, granulocyte monocyte-colony stimulating factor
- IFNγ, interferon γ
- IL, interleukin
- M-CSF, monocyte/macrophage-colony stimulating factor
- α-MEM, α-minimal essential medium
- MFI, mean fluorescence intensity
- OPG, osteoprotegerin
- PBS, phosphate buffered saline
- PHA, phytohaemagglutinin
- RA, rheumatoid arthritis
- RANK, receptor activator of NF-κB
- RANKL, receptor activator of NF-κB ligand
- TNFα, tumour necrosis factor α
- TRAP, tartrate resistant acid phosphatase
- interleukin 18
- interleukin 1β
- tumour necrosis factor α
- osteoclasts
- rheumatoid arthritis